Breaking News Instant updates and real-time market news.

PZZA

Papa John's

$99.35 /

-0.18 (-0.18%)

07:15
08/25/20
08/25
07:15
08/25/20
07:15

Papa John's reports preliminary August period comparable sales figures

Papa John's provided preliminary estimated comparable sales information for the August fiscal period, or July 27 through August 23. In light of the uncertainty and volatility related to the pandemic, the company has continued to provide this information on a monthly basis. The company reports domestic company-owned comparable sales growth of 18%, North America franchised comparable sales growth of 26.1%, system-wide North America comparable sales growth of 24.2% and system-wide international comparable sales growth of 23.3%. Of the company's approximately 2,100 international franchised stores, the number temporarily closed has declined to approximately 150, primarily in Latin America and Europe, in accordance with government policies. In North America, almost all traditional restaurants remain open and fully operational. A number of non-traditional restaurants located in universities and stadiums are temporarily closed; these non-traditional locations are not material to the company's revenues and operating results.

PZZA Papa John's
$99.35 /

-0.18 (-0.18%)

08/07/20 CL King
Papa John's price target raised to $110 from $90 at CL King
08/07/20 Stephens
Papa John's price target raised to $108 from $94 at Stephens
08/07/20 BTIG
Papa John's price target raised to $115 from $95 at BTIG
08/07/20 Credit Suisse
Papa John's price target raised to $110 from $90 at Credit Suisse

TODAY'S FREE FLY STORIES

Initiation
Cornerstone OnDemand initiated with a Market Perform at BMO Capital » 04:59
09/23/20
09/23
04:59
09/23/20
04:59
CSOD

Cornerstone OnDemand

$34.69 /

+0.27 (+0.78%)

BMO Capital analyst Keith…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CSOD Cornerstone OnDemand
$34.69 /

+0.27 (+0.78%)

CSOD Cornerstone OnDemand
$34.69 /

+0.27 (+0.78%)

07/27/20
Fly Intel: Top five analyst downgrades
07/27/20 BofA
Cornerstone OnDemand double-downgraded to Underperform from Buy at BofA
07/27/20 BofA
Cornerstone OnDemand downgraded to Underperform from Buy at BofA
06/29/20 Goldman Sachs
Cornerstone OnDemand price target raised to $46 from $37 at Goldman Sachs
CSOD Cornerstone OnDemand
$34.69 /

+0.27 (+0.78%)

Recommendations
Nike price target raised to $140 from $137 at Pivotal Research » 04:57
09/23/20
09/23
04:57
09/23/20
04:57
NKE

Nike

$116.98 /

+3.67 (+3.24%)

Pivotal Research analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NKE Nike
$116.98 /

+3.67 (+3.24%)

NKE Nike
$116.98 /

+3.67 (+3.24%)

09/22/20 Baird
Nike price target raised to $115 but limited upside seen, says Baird
09/18/20 Needham
Nike price target raised to $132 from $113 at Needham
09/18/20 Morgan Stanley
Nike price target raised to $142 from $121 at Morgan Stanley
09/18/20 Raymond James
Nike price target raised to $121 from $115 at Raymond James
NKE Nike
$116.98 /

+3.67 (+3.24%)

NKE Nike
$116.98 /

+3.67 (+3.24%)

NKE Nike
$116.98 /

+3.67 (+3.24%)

NKE Nike
$116.98 /

+3.67 (+3.24%)

Upgrade
Twitter upgraded to Buy from Hold at Pivotal Research » 04:55
09/23/20
09/23
04:55
09/23/20
04:55
TWTR

Twitter

$42.73 /

+2.84 (+7.12%)

Pivotal Research analyst…

Pivotal Research analyst Michael Levine upgraded Twitter to Buy from Hold with a price target of $59.75, up from $36. The stock closed Tuesday up $2.83 to $42.73. The analyst likes the Olympics coming in 2021, direct response beginning to kick in, and Twitter's potential subscription business. The company's Q3 earnings report and forward commentary are likely to act as positive catalysts for the stock, Levine tells investors in a research note. In addition, investor sentiment is "by far the most negative in our coverage" and as a result, the "rubber band for stock out-performance the greatest," says the analyst. Levine believes the changes Twitter has made around the process of onboarding new users over the last few months has meaningfully improved.

ShowHide Related Items >><<
TWTR Twitter
$42.73 /

+2.84 (+7.12%)

TWTR Twitter
$42.73 /

+2.84 (+7.12%)

09/15/20
Fly Intel: Top five analyst initiations
09/14/20 KeyBanc
Twitter initiated with a Sector Weight at KeyBanc
09/14/20 KeyBanc
Twitter initiated with a Sector Weight at KeyBanc
09/03/20 Cleveland Research
Twitter pace of recovery looks slower than peers, says Cleveland Research
TWTR Twitter
$42.73 /

+2.84 (+7.12%)

TWTR Twitter
$42.73 /

+2.84 (+7.12%)

TWTR Twitter
$42.73 /

+2.84 (+7.12%)

TWTR Twitter
$42.73 /

+2.84 (+7.12%)

General news
Week of 9/18 MBA Mortgage Applications to be released at 07:00  04:55
09/23/20
09/23
04:55
09/23/20
04:55
 
Conference/Events
UBS technology analyst to hold an analyst/industry conference call » 04:55
09/23/20
09/23
04:55
09/23/20
04:55

Technology Analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Conference/Events
Gibraltar Industries management to meet virtually with KeyBancc » 04:55
09/23/20
09/23
04:55
09/23/20
04:55
ROCK

Gibraltar Industries

$62.07 /

+0.26 (+0.42%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ROCK Gibraltar Industries
$62.07 /

+0.26 (+0.42%)

ROCK Gibraltar Industries
$62.07 /

+0.26 (+0.42%)

05/07/20 KeyBanc
Gibraltar Industries price target lowered to $55 from $60 at KeyBanc
03/23/20 Sidoti
Gibraltar Industries upgraded to Buy from Neutral at Sidoti
ROCK Gibraltar Industries
$62.07 /

+0.26 (+0.42%)

Conference/Events
UBS healthcare analysts to hold an analyst/industry conference call » 04:55
09/23/20
09/23
04:55
09/23/20
04:55

Healthcare Analysts Mayo,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Conference/Events
Assured Guaranty participates in a conference call hosted by MKM Partners » 04:55
09/23/20
09/23
04:55
09/23/20
04:55
AGO

Assured Guaranty

$19.33 /

+0.125 (+0.65%)

MKM Partners host…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AGO Assured Guaranty
$19.33 /

+0.125 (+0.65%)

08/07/20 MKM Partners
Assured Guaranty price target lowered to $45 from $65 at MKM Partners
AGO Assured Guaranty
$19.33 /

+0.125 (+0.65%)

Conference/Events
Ellington Financial management to meet virtually with JMP Securities » 04:55
09/23/20
09/23
04:55
09/23/20
04:55
EFC

Ellington Financial

$12.57 /

+0.1 (+0.80%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 8 minutes

Get Free Trial

ShowHide Related Items >><<
EFC Ellington Financial
$12.57 /

+0.1 (+0.80%)

EFC Ellington Financial
$12.57 /

+0.1 (+0.80%)

07/13/20 BofA
Ellington Financial initiated with a Neutral at BofA
07/13/20 BofA
Ellington Financial initiated with a Neutral at BofA
04/09/20 Piper Sandler
Mortgage Finance volatility brings 'unique opportunity,' says Piper Sandler
09/27/19 Nomura Instinet
Ellington Financial initiated with a Buy at Nomura Instinet
EFC Ellington Financial
$12.57 /

+0.1 (+0.80%)

  • 22
    Jan
  • 19
    Nov
General news
Chicago Federal Reserve Bank President Charles Evans Speech to be released at 11:00  04:55
09/23/20
09/23
04:55
09/23/20
04:55
 
General news
Federal Reserve Vice Chair for Supervision Randal Quarles Speech to be released at 00:00  04:55
09/23/20
09/23
04:55
09/23/20
04:55
 
Conference/Events
Goldman Sachs to hold a virtual conference » 04:55
09/23/20
09/23
04:55
09/23/20
04:55
LLY

Eli Lilly

$149.93 /

-1.3 (-0.86%)

, MRNA

Moderna

$68.73 /

-0.58 (-0.84%)

, GS

Goldman Sachs

$191.64 /

-2.37 (-1.22%)

Next Phase of Healthcare,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 8 minutes

Get Free Trial

ShowHide Related Items >><<
LLY Eli Lilly
$149.93 /

-1.3 (-0.86%)

MRNA Moderna
$68.73 /

-0.58 (-0.84%)

GS Goldman Sachs
$191.64 /

-2.37 (-1.22%)

LLY Eli Lilly
$149.93 /

-1.3 (-0.86%)

09/21/20 Morgan Stanley
Eli Lilly's Verzenio 'clear winner' over Pfizer's Ibrance, says Morgan Stanley
09/16/20 Canaccord
Eli Lilly COVID-19 data bodes well for Regeneron, says Canaccord
09/16/20 Goldman Sachs
Eli Lilly COVID-19 antibody data 'encouraging,' says Goldman Sachs
09/07/20 Piper Sandler
Early approval of Blueprint's Gavreto 'a nice surprise,' says Piper Sandler
MRNA Moderna
$68.73 /

-0.58 (-0.84%)

09/18/20 Needham
Moderna shares attractive long term on mRNA platform and pipeline, says Needham
09/17/20 Jefferies
Moderna COVID trial stats suggest late Oct. or Nov. for data, says Jefferies
09/09/20 SVB Leerink
AstraZeneca pause 'a mixed blessing for Moderna, others, says SVB Leerink
09/08/20
Fly Intel: Top five analyst downgrades
GS Goldman Sachs
$191.64 /

-2.37 (-1.22%)

08/06/20 Piper Sandler
Now is the time to buy Goldman Sachs, says Piper Sandler
07/20/20 Berenberg
Goldman Sachs price target raised to $200 from $160 at Berenberg
07/16/20 DA Davidson
Goldman Sachs price target raised to $238 from $215 at DA Davidson
07/16/20 Oppenheimer
Goldman Sachs price target raised to $355 from $335 at Oppenheimer
LLY Eli Lilly
$149.93 /

-1.3 (-0.86%)

MRNA Moderna
$68.73 /

-0.58 (-0.84%)

GS Goldman Sachs
$191.64 /

-2.37 (-1.22%)

  • 19
    May
  • 12
    Feb
LLY Eli Lilly
$149.93 /

-1.3 (-0.86%)

MRNA Moderna
$68.73 /

-0.58 (-0.84%)

GS Goldman Sachs
$191.64 /

-2.37 (-1.22%)

LLY Eli Lilly
$149.93 /

-1.3 (-0.86%)

MRNA Moderna
$68.73 /

-0.58 (-0.84%)

GS Goldman Sachs
$191.64 /

-2.37 (-1.22%)

LLY Eli Lilly
$149.93 /

-1.3 (-0.86%)

MRNA Moderna
$68.73 /

-0.58 (-0.84%)

GS Goldman Sachs
$191.64 /

-2.37 (-1.22%)

Conference/Events
Cardiff Oncology to hold a KOL conference call » 04:55
09/23/20
09/23
04:55
09/23/20
04:55
CRDF

Cardiff Oncology

$11.67 /

+0.1 (+0.86%)

Management holds a Key…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CRDF Cardiff Oncology
$11.67 /

+0.1 (+0.86%)

CRDF Cardiff Oncology
$11.67 /

+0.1 (+0.86%)

09/18/20 Maxim
Cardiff Oncology price target raised to $14 from $6 at Maxim
CRDF Cardiff Oncology
$11.67 /

+0.1 (+0.86%)

Conference/Events
UBS leisure, gaming & lodging analyst to hold analyst/industry conference call » 04:55
09/23/20
09/23
04:55
09/23/20
04:55

Leisure, Gaming &…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Conference/Events
Sykes Enterprises management to meet virtually with Barrington » 04:55
09/23/20
09/23
04:55
09/23/20
04:55
SYKE

Sykes Enterprises

$32.94 /

+1.39 (+4.41%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SYKE Sykes Enterprises
$32.94 /

+1.39 (+4.41%)

09/22/20 Baird
Sykes Enterprises desiganted as a Fresh Pick at Baird
06/04/20 Baird
Sykes Enterprises upgraded to Outperform at Baird
06/04/20 Baird
Sykes Enterprises upgraded to Outperform from Neutral at Baird
03/16/20 Sidoti
Sykes Enterprises upgraded to Buy from Neutral at Sidoti
SYKE Sykes Enterprises
$32.94 /

+1.39 (+4.41%)

SYKE Sykes Enterprises
$32.94 /

+1.39 (+4.41%)

Conference/Events
Nutanix management to meet virtually with KeyBanc » 04:55
09/23/20
09/23
04:55
09/23/20
04:55
NTNX

Nutanix

$22.70 /

+1.06 (+4.90%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NTNX Nutanix
$22.70 /

+1.06 (+4.90%)

NTNX Nutanix
$22.70 /

+1.06 (+4.90%)

08/28/20
Fly Intel: Top five analyst downgrades
08/28/20 Stifel
Nutanix model shift impacts may not be fully appreciated, says Stifel
08/28/20 Baird
Nutanix downgraded to Neutral from Outperform at Baird
08/21/20 Cleveland Research
Nutanix estimates at risk over next several quarters, says Cleveland Research
NTNX Nutanix
$22.70 /

+1.06 (+4.90%)

NTNX Nutanix
$22.70 /

+1.06 (+4.90%)

NTNX Nutanix
$22.70 /

+1.06 (+4.90%)

NTNX Nutanix
$22.70 /

+1.06 (+4.90%)

Conference/Events
UBS consumer goods analyst to hold an analyst/industry conference call » 04:55
09/23/20
09/23
04:55
09/23/20
04:55
NKE

Nike

$116.98 /

+3.67 (+3.24%)

Consumer Analyst Sole,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NKE Nike
$116.98 /

+3.67 (+3.24%)

NKE Nike
$116.98 /

+3.67 (+3.24%)

09/22/20 Baird
Nike price target raised to $115 but limited upside seen, says Baird
09/18/20 Needham
Nike price target raised to $132 from $113 at Needham
09/18/20 Morgan Stanley
Nike price target raised to $142 from $121 at Morgan Stanley
09/18/20 Raymond James
Nike price target raised to $121 from $115 at Raymond James
NKE Nike
$116.98 /

+3.67 (+3.24%)

NKE Nike
$116.98 /

+3.67 (+3.24%)

NKE Nike
$116.98 /

+3.67 (+3.24%)

NKE Nike
$116.98 /

+3.67 (+3.24%)

General news
FHFA House Price Index Month over Month to be reported at 09:00 » 04:55
09/23/20
09/23
04:55
09/23/20
04:55

July FHFA House Price…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 8 minutes

Get Free Trial

Conference/Events
Goldman Sachs to hold a virtual conference » 04:55
09/23/20
09/23
04:55
09/23/20
04:55

9th German Corporate…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 8 minutes

Get Free Trial

Conference/Events
FTI Consulting management to meet virtually with Truist » 04:55
09/23/20
09/23
04:55
09/23/20
04:55
FCN

FTI Consulting

$107.78 /

-0.47 (-0.43%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 8 minutes

Get Free Trial

ShowHide Related Items >><<
FCN FTI Consulting
$107.78 /

-0.47 (-0.43%)

FCN FTI Consulting
$107.78 /

-0.47 (-0.43%)

05/01/20 Sidoti
FTI Consulting upgraded to Buy from Neutral at Sidoti
04/15/20 Sidoti
FTI Consulting downgraded to Neutral from Buy at Sidoti
04/06/20 William Blair
FTI Consulting upgraded to Outperform from Market Perform at William Blair
01/17/20 SunTrust
FTI Consulting price target raised to $155 from $130 at SunTrust
FCN FTI Consulting
$107.78 /

-0.47 (-0.43%)

Conference/Events
ImmunoGen management to meet virtually with William Blair » 04:55
09/23/20
09/23
04:55
09/23/20
04:55
IMGN

ImmunoGen

$3.85 /

+0.035 (+0.92%)

Virtual Meetings to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
IMGN ImmunoGen
$3.85 /

+0.035 (+0.92%)

IMGN ImmunoGen
$3.85 /

+0.035 (+0.92%)

09/18/20 Piper Sandler
Piper Sandler lays out next potential takeover targets in oncology
05/04/20 H.C. Wainwright
ImmunoGen shares offer 'compelling entry point,' says H.C. Wainwright
12/17/19 H.C. Wainwright
ImmunoGen price target hiked to $9 after 'compelling' advance at H.C. Wainwright
09/29/19 Piper Jaffray
Biomarker screening reason for ImmunoGen FORWARD I failure, says Piper Jaffray
IMGN ImmunoGen
$3.85 /

+0.035 (+0.92%)

  • 21
    Jan
IMGN ImmunoGen
$3.85 /

+0.035 (+0.92%)

Conference/Events
Shoe Carnival management to meet virtually with Wedbush » 04:55
09/23/20
09/23
04:55
09/23/20
04:55
SCVL

Shoe Carnival

$37.07 /

+0.2 (+0.54%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 8 minutes

Get Free Trial

ShowHide Related Items >><<
SCVL Shoe Carnival
$37.07 /

+0.2 (+0.54%)

SCVL Shoe Carnival
$37.07 /

+0.2 (+0.54%)

09/02/20
Fly Intel: Top five analyst downgrades
09/02/20 Sidoti
Shoe Carnival downgraded to Neutral from Buy at Sidoti
09/02/20 Susquehanna
Shoe Carnival weakness a buying opportunity, says Susquehanna
07/01/20 Pivotal Research
Shoe Carnival price target raised to $42 from $37 at Pivotal Research
SCVL Shoe Carnival
$37.07 /

+0.2 (+0.54%)

SCVL Shoe Carnival
$37.07 /

+0.2 (+0.54%)

SCVL Shoe Carnival
$37.07 /

+0.2 (+0.54%)

General news
Atlanta Federal Reserve Bank President Raphael Bostic Speech to be released at 13:00  04:55
09/23/20
09/23
04:55
09/23/20
04:55
 
Conference/Events
Wabtec participates in a conference call hosted by Stephens » 04:55
09/23/20
09/23
04:55
09/23/20
04:55
WAB

Wabtec

$62.20 /

-0.79 (-1.25%)

Stephens Managing…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
WAB Wabtec
$62.20 /

-0.79 (-1.25%)

WAB Wabtec
$62.20 /

-0.79 (-1.25%)

07/29/20 Wells Fargo
Wabtec price target raised to $80 from $75 at Wells Fargo
07/29/20 Citi
Wabtec price target raised to $70 from $60 at Citi
07/07/20 Wolfe Research
Wabtec downgraded to Underperform from Peer Perform at Wolfe Research
06/03/20
Fly Intel: Top five analyst downgrades
WAB Wabtec
$62.20 /

-0.79 (-1.25%)

WAB Wabtec
$62.20 /

-0.79 (-1.25%)

Conference/Events
USA Technologies management to meet virtually with Barrington » 04:55
09/23/20
09/23
04:55
09/23/20
04:55
USAT

USA Technologies

$4.36 /

+ (+0.00%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
USAT USA Technologies
$4.36 /

+ (+0.00%)

USAT USA Technologies
$4.36 /

+ (+0.00%)

06/26/20 Barrington
USA Technologies reinstated with an Outperform at Barrington
10/15/19 William Blair
William Blair resumes USA Technologies at Outperform, sees takeout potential
10/11/19
Fly Intel: Top five analyst upgrades
10/11/19 Lake Street
USA Technologies upgraded to Buy from Hold at Lake Street
USAT USA Technologies
$4.36 /

+ (+0.00%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.